MDS clinical diagnostic criteria for Parkinson's diseaseRonald B. Postuma, Günther Deuschl, Daniela Berg et al.|Movement Disorders|2015Cited by 7.4k
MDS research criteria for prodromal Parkinson's diseaseDaniela Berg, Günther Deuschl, Ronald B. Postuma et al.|Movement Disorders|2015Cited by 1.3k
A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's DiseaseC. Warren Olanow, Eduardo Tolosa|New England Journal of Medicine|2009Cited by 889
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking PalsyJosé Á. Obeso, A. Jon Stoessl, María Stamelou et al.|Movement Disorders|2017Cited by 846
Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerationsBenjamin Dehay, Wassilios G. Meissner, Gregory A. Petsko et al.|The Lancet Neurology|2015Cited by 508